Life-Threatening Interactions Between HIV-1 Protease Inhibitors and the Illicit Drugs MDMA and γ-Hydroxybutyrate
- 11 October 1999
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 159 (18), 2221-2224
- https://doi.org/10.1001/archinte.159.18.2221
Abstract
Case Report from JAMA Internal Medicine — Life-Threatening Interactions Between HIV-1 Protease Inhibitors and the Illicit Drugs MDMA and γ-HydroxybutyrateKeywords
This publication has 4 references indexed in Scilit:
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Human immunodeficiency virus type 1 protease inhibitors.Archives of Internal Medicine, 1997
- A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 ProteaseNew England Journal of Medicine, 1995